share_log

Jin Medical International | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jin Medical International | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

中進醫療 | 6-K:外國發行人報告
美股SEC公告 ·  2024/10/12 04:14

牛牛AI助理已提取核心訊息

On October 10, 2024, Jin Medical International Ltd., a leader in Assistive Technologies and a manufacturer of wheelchairs and living aids, announced the start of construction for a new manufacturing facility in Chuzhou City, Anhui Province, China. The new subsidiary, JinMed (Anhui) Co., Ltd., will operate the facility, which is expected to be an internationally standardized, innovative, and high-end wheelchair and electric wheelchair manufacturing factory. The facility, which is set to begin operations in 2025, will expand the company's capacity for manual wheelchairs and introduce new lines for electric wheelchairs, electric scooters, micro hyperbaric chambers, and scientific cosmetic products. JinMed's Chairman and CEO, Mr. Wang Erqi, highlighted the new facility as a significant milestone and a step towards strengthening the...Show More
On October 10, 2024, Jin Medical International Ltd., a leader in Assistive Technologies and a manufacturer of wheelchairs and living aids, announced the start of construction for a new manufacturing facility in Chuzhou City, Anhui Province, China. The new subsidiary, JinMed (Anhui) Co., Ltd., will operate the facility, which is expected to be an internationally standardized, innovative, and high-end wheelchair and electric wheelchair manufacturing factory. The facility, which is set to begin operations in 2025, will expand the company's capacity for manual wheelchairs and introduce new lines for electric wheelchairs, electric scooters, micro hyperbaric chambers, and scientific cosmetic products. JinMed's Chairman and CEO, Mr. Wang Erqi, highlighted the new facility as a significant milestone and a step towards strengthening the company's leadership in the AT industry. JinMed, founded in 2006 and headquartered in Changzhou, Jiangsu Province, currently operates two manufacturing plants and has a network of over 40 distributors in China and more than 20 international distributors. The majority of its products are sold in Japan and China, with Nissin Medical Industries Co., Ltd. being one of its largest distributors.
2024年10月10日,中進醫療國際有限公司,一家輔助技術領域的領先企業和輪椅及生活輔助產品製造商,宣佈在中國安徽省滁州市新開設製造工廠的施工工作。預計總部位於滁州的全資子公司中進醫療(安徽)有限公司將負責這家工廠的運營,該工廠預計將成爲一個國際標準化、創新性和高端的輪椅和電動輪椅製造工廠。這家工廠預計將於2025年投入運營,將擴大公司手動輪椅的產能,並引入新的電動輪椅、電動摩托車、微型高壓氧艙和科學化妝品產品線。中進醫療董事長兼首席執行官王二起先生將這家新工廠視爲一個重要里程碑,是加強公司在輔助技術行業領導地位的一步。成立於2006年的中進醫療總部位於江蘇常州,目前擁有兩家制造工廠,在中國境內擁有超過40家經銷商網絡,在海外擁有超過20家國際經銷商。其大部分產品在日本和中國銷售,而日本Nissin醫療工業有限公司是其最大的分銷商之一。
2024年10月10日,中進醫療國際有限公司,一家輔助技術領域的領先企業和輪椅及生活輔助產品製造商,宣佈在中國安徽省滁州市新開設製造工廠的施工工作。預計總部位於滁州的全資子公司中進醫療(安徽)有限公司將負責這家工廠的運營,該工廠預計將成爲一個國際標準化、創新性和高端的輪椅和電動輪椅製造工廠。這家工廠預計將於2025年投入運營,將擴大公司手動輪椅的產能,並引入新的電動輪椅、電動摩托車、微型高壓氧艙和科學化妝品產品線。中進醫療董事長兼首席執行官王二起先生將這家新工廠視爲一個重要里程碑,是加強公司在輔助技術行業領導地位的一步。成立於2006年的中進醫療總部位於江蘇常州,目前擁有兩家制造工廠,在中國境內擁有超過40家經銷商網絡,在海外擁有超過20家國際經銷商。其大部分產品在日本和中國銷售,而日本Nissin醫療工業有限公司是其最大的分銷商之一。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。